Physician

Benjamin Joseph Nichols, MD

According to 2025 Medicare claims, Benjamin Nichols, MD (NPI: 1790983237) practices dermatology in the San Rafael, CA market, with the plurality of this provider's patient population coming from Marin, CA. This provider's primary affiliated billing organization is GREENBRAE DERMATOLOGY, A MEDICAL CORPORATION (NPI: 1174898654; TIN: 45-4125969) and primary practice location at 94904-2305.

Nichols' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,577 traditional Medicare patients, billed 9,865 HCPCS/CPT codes, and received $717,395 in Medicare payments. The top billing code was 17004 (Destruction of precancer skin growth, 15 or more growths). Part D data shows 1,092 prescription claims across 456 beneficiaries totaling $292,125 in drug costs, led by Otezla (Apremilast). Open Payments data shows 66 records totaling $1,727. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $166,753 to $717,395. Similarly, Part D prescription costs have risen steadily, from $98,443 to $292,125. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$359K$717K2015 Medicare payment: $166,753 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $138,951 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $175,538 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $230,202 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $284,944 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $359,394 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $475,789 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $506,573 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $598,631 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $717,395 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157273,543$166,753
20166953,370$138,951
20177103,756$175,538
20189215,279$230,202
20191,0807,830$284,944
20201,3578,585$359,394
20211,3158,876$475,789
20221,4289,248$506,573
20231,4809,497$598,631
20241,5779,865$717,395

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$146K$292K2015 Drug cost: $98,443 (USD; Tot_Drug_Cst)2016 Drug cost: $85,475 (USD; Tot_Drug_Cst)2017 Drug cost: $49,676 (USD; Tot_Drug_Cst)2018 Drug cost: $70,743 (USD; Tot_Drug_Cst)2019 Drug cost: $49,420 (USD; Tot_Drug_Cst)2020 Drug cost: $114,316 (USD; Tot_Drug_Cst)2021 Drug cost: $182,986 (USD; Tot_Drug_Cst)2022 Drug cost: $105,920 (USD; Tot_Drug_Cst)2023 Drug cost: $169,398 (USD; Tot_Drug_Cst)2024 Drug cost: $292,125 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015268544$98,443
2016281542$85,475
2017328642$49,676
2018328689$70,743
2019393832$49,420
20205701,228$114,316
20215341,137$182,986
2022453957$105,920
20234731,038$169,398
20244561,092$292,125

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17004Destruction of precancer skin growth, 15 or more growths323458$173
11102Biopsy of related skin growth, first growth370422$99
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more1,1161,725$79
17000Destruction of precancer skin growth, 1 growth758959$56
17003Destruction of precancer skin growth, 2-14 growths6393,365$7

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OtezlaApremilast24720$111,802
Cosentyx (2 Syringes)Secukinumab14392$103,767
Clobetasol PropionateClobetasol Propionate933,186$6,303
MetronidazoleMetronidazole421,258$2,270
MinoxidilMinoxidil21616,047$2,214

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.66$1,727Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Benjamin Joseph Nichols, MD?

Tedicare shows public-source Medicare data for Benjamin Joseph Nichols, MD (NPI 1790983237), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Benjamin Joseph Nichols, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Benjamin Joseph Nichols, MD?

Benjamin Joseph Nichols, MD is linked to GREENBRAE DERMATOLOGY, A MEDICAL CORPORATION (billing NPI 1174898654) in the available physician profile data.

Does Benjamin Joseph Nichols, MD have Open Payments data?

Benjamin Joseph Nichols, MD has 66 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.